May 29, 2020
Generic-drug maker Mylan convinced the Patent Trial and Appeal Board to nix a handful of Sanofi-Aventis patents Friday covering the Lantus SoloStar disposable insulin injection pen, adding to its past wins in cases related to the same product.
February 05, 2020
Mylan urged the Patent Trial and Appeal Board on Wednesday to reject Sanofi-Aventis' substitute claims to insulin pen patents that were the first to pass through a new program that provides early feedback on proposed amendments.
October 18, 2019
Sanofi's proposed adjustments to insulin patents being challenged by Mylan likely won't pass muster, the Patent Trial and Appeal Board has said in its first-ever guidance under a new program that provides early feedback on proposed amendments.